Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Papillomavirus Infections × Colposcopy × Clear all

Phase

Phase NA 6 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Dysplasia 2 Uterine Cervical Neoplasms 1 Papillomavirus Infections 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 21 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 14 Papillomavirus Vaccines 9 Vaccines 6 Blood Specimen Collection 3 Watchful Waiting 2 Vaccines, Synthetic 2 Light Coagulation 2 Hepatitis A Vaccines 2 Engerix-B 2 lime 1 halofantrine 1 Sodium Chloride 1 Radiotherapy, Intensity-Modulated 1 Pentetic Acid 1 Olive Oil 1 Observation 1 Measles-Mumps-Rubella Vaccine 1 Laser Therapy 1 Injections 1 Imiquimod 1 Human Papillomavirus DNA Tests 1 Fluorouracil 1 Diphtheria-Tetanus-acellular Pertussis Vaccines 1 DTPa-HBV-IPV combined vaccine 1 Colposcopy 1 Cisplatin 1 Circumcision, Male 1 Chorionic Villi Sampling 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04794660 2024-03-13

CESTA

International Agency for Research on Cancer

Phase 3 Active not recruiting

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡